Amplifi

Passage of the Amendment to the Advanced Regenerative Biotech Act a Positive Catalyst for Korean and Japanese Cell Therapy Companies

Source Node:
Time Stamp: February 7, 2024 10:49 AM - Modified On: February 7, 2024 - Published By:
Source Cluster:
Republished By Plato

Legislation Puts Renewed Focus on Next-Generation NK Cell Therapies New York, Feb 7, 2024 - (Plato Data) - On Thursday February 2, 2024, the bio industry welcomed the parliament’s passage of a bill that adds regenerative medicine organizations to the list of those considered for human cell management business licenses. The National Assembly passed the “Amendment to the Act on Safety and Support for Advanced Regenerative Medicine and Advanced Biopharmaceuticals” in a plenary session paving the way for certain next generation NK Cell Therapy companies to recognized as a licensed

Lindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries

Source Node:
Time Stamp: February 2, 2024 2:30 PM - Modified On: February 2, 2024 - Published By:
Source Cluster:
Republished By Plato

  New York, Feb 2, 2024 - (Plato Data)- Fortress Biotech (Fortress Bio), a unique biotech company led by industry veteran Dr. Lindsay Rosenwald, focused on identifying, in-licensing and developing high-potential marketed drugs and development-stage drug candidates in-house and through its subsidiary partner companies, has announced multiple new milestones to start 2024 with a bang. Avenue Therapeutics Finalizes Phase 3 Study for IV Tramadol with FDA Avenue Therapeutics, a subsidiary of Fortress Bio, has reached a significant milestone in its quest to introduce new therapies for neurologic diseases. The company

Investors Take Note as Corbus Pharma Releases Data for ADC Tumor Candidate

Source Node:
Time Stamp: January 29, 2024 6:55 AM - Modified On: January 29, 2024 - Published By:
Source Cluster:
Republished By Plato

New York, Jan. 29, 2024 - (Plato Data) - Corbus Pharmaceuticals (NASDAQ:CRBP) jumped on Friday after announcing positive data from a small group of cancer patients who received its antibody-drug conjugate (ADC) CRB-701 in a Phase 1 trial. Citing a December data cut in patients with cancers expressing a tumor-associated antigen called nectin-4, Corbus (CRBP) said that CRB-701 led to an objective response rate (ORR) of 43%, including three partial responses. The data from the first eighteen participants who received the first six dose levels represented the readout, which was

NEWHD, New York, Where Rock Lives, to Honor Veterans with a 21 Hour Classic Rock Salute.

Source Node:
Time Stamp: November 9, 2023 5:22 AM - Modified On: November 9, 2023 - Published By:
Source Cluster:
Republished By Plato

NEWHD, New York, November 8, 2023- NEWHD, New York's premier rock radio station, is set to pay tribute to our nation's veterans with a remarkable event - a 21 Hour Classic Rock Salute, hosted by the renowned Rock Chap Bill Wade. This special program will exclusively feature classic rock hits cherished by veterans, accompanied by essential information from the Veterans Administration, including crucial insights on Suicide Prevention. Zach Martin, the Founder of NEWHD, emphasizes the significance of tangible support for veterans, stating, "Veterans need to be supported by actions and

PureTalk AI Collaborates with Plato AI to Launch Innovative WebApp Empowering Conversational AI.

Source Node:
Time Stamp: November 8, 2023 5:03 AM - Modified On: November 8, 2023 - Published By:
Source Cluster:
Republished By Plato

November 7, 2023. New York, NY – Puretalk AI, a leading provider of advanced conversational AI solutions, is thrilled to announce its exciting collaboration with Plato, a pioneer in machine learning and AI technology. Together, they are launching a cutting-edge website Widget designed to revolutionize the way websites engage with visitors. This groundbreaking widget, which leverages Puretalk AI's machine learning capabilities and humanized Text-to-Speech (TTS+) technology, will transform static websites into interactive, conversational platforms. The new website Widget, aptly named "Socrates," has been engineered to dynamically learn and adapt to

NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.

Source Node:
Time Stamp: October 24, 2023 11:54 AM - Modified On: October 24, 2023 - Published By:
Source Cluster:
Republished By Plato

Summary: Progress in Neurodegenerative Research:  NKGen’s Phase 1/2a Clinical Trial for SNK01 on Track for End-of-Year Initiation SANTA ANA, Calif., Oct. 24, 2023 (Plato / Amplifi) -- Today, NKGen Biotech Inc. (Nasdaq: NKGN), a trailblazer in the field of autologous, allogeneic, and CAR-NK natural killer cell therapeutics, proudly announced the progression of its SNK01 program targeting Alzheimer’s Disease (AD), backed by the green light from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application. NKGen is gearing up to initiate its Phase 1/2a clinical trial

Starbox Group Holdings Ltd. Announces First Half of Fiscal Year 2023 Financial Results

Source Node:
Time Stamp: August 29, 2023 11:37 AM - Modified On: August 29, 2023 - Published By:
Source Cluster:
Republished By Plato

Revenue and Net Profit Increased with Technology Driven Services Revenue Accounted for Approximately 43.8% of its Revenue KUALA LUMPUR, Malaysia, August 29, 2023 / Plato / Amplifi. Starbox Group Holdings Ltd. (Nasdaq: STBX) ("Starbox" or "the Company”), a service provider of cash rebates, digital advertising, and payment solutions with a goal of becoming a comprehensive AI solutions provider within Southeast Asia, today announced its unaudited financial results for the six months ended March 31, 2023. Mr. Lee Choon Wooi, Chairman and Chief Executive Officer of Starbox, commented, “We are excited

Government Blockchain Association (GBA) Deploys PlatoAi across GBA’s Opensource Intelligence Platform (OSINT)

Source Node:
Time Stamp: July 6, 2023 11:44 AM - Modified On: July 6, 2023 - Published By:
Source Cluster:
Republished By Plato

Washington DC, July 6th, 2023. Government Blockchain Association (GBA) announced the successful deployment of PlatoAi’s Ai Powered Web3 Intelligence inside the GBA Members Site. The result of this successful deployment stemmed from a strategic partnership between the two companies with a collective vision and deep commitment towards driving commercial adoption, standards and regulatory compliance of global government blockchain initiatives. Through this deployment GBA’s community will immediately benefit by accessing the latest premium intelligence across 36 Market Verticals including Ai, Digital Assets, Regulatory Initiatives, Web3, NFT’s, CyberSecurity, ESG and Carbon Offsets.

Why Press Releases are Still an Effective Way to Market Your Business

Source Node:
Time Stamp: July 3, 2023 7:07 AM - Modified On: July 3, 2023 - Published By:
Source Cluster:
Republished By Plato

Even in the Age of Social Media, Press Releases are still an important tool for businesses of all sizes to grow their brand awareness, improve media relations, and to build consumer confidence, and should continued to be used to announce new products or services, promote events, or share other newsworthy information about the company. Key benefits of using press releases to grow your business: Increase brand awareness: Press releases help you reach outside your Social Media subscriber base to a wider audience and introduce your brand to new potential customers.

Redmatter.Capital Deploys PlatoAi across its Web3 Content and Data Intelligence

Source Node:
Time Stamp: June 12, 2023 11:56 AM - Modified On: June 12, 2023 - Published By:
Source Cluster:
Republished By Plato

Montenegro, June 10th, 2023. Redmatter.Capital a fully regulated platform digital assets today announced the successful deployment of PlatoAi’s Ai Powered Web3 Intelligence inside the Redmatter Platform. The result of this successful deployment stemmed from a strategic partnership between the two companies with a collective vision and deep commitment towards driving commercial adoption and regulatory compliance of Digital Assets. Through this deployment Redmatter’s community of users will immediately benefit by accessing the latest premium intelligence across the digital asset sector including Web3, NFT’s, Trading and Carbon Offsets. Both companies plan to

Linkedin Influencer Rachel Mitchell Joins Plato’s Board. Joint Venture Announced.

Source Node:
Time Stamp: March 6, 2023 11:19 AM - Modified On: March 6, 2023 - Published By:
Source Cluster:
Republished By Plato

March 6, 2022. New York NY. The JV was setup to drive both awareness and user adoption of Plato’s Ai Powered Content Syndication Network. The global partnership leverages over 30 years of technical and marketing excellence across today’s most innovative market sectors. Key Highlights: Rachel Mitchell EP of Innovation Series is the First LinkedIn Influencer with Almost 1M followers joins Plato’s Board to help drive Commercial Web3 Adoption. Joint Venture Announced to Disrupt PR & Content Syndication across the innovation superhighway via Amplifi Subsidiary. Plato's Ai Engine uses its internal